MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CANN, J. R.
Right arrow Articles by WINZOR, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CANN, J. R.
Right arrow Articles by WINZOR, D. J.

Molecular Pharmacology, Vol 20, 244-245, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Micellarization of Chlorpromazine

Implications in the Binding of the Drug to Brain Tubulin

JOHN R. CANN 1, LAWRENCE W. NICHOL 1, and DONALD J. WINZOR 1

1 Department of Biophysics and Genetics, University of Colorado Medical Center, Denver, Colorado 80220, Department of Physical Biochemistry, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, and Department of Biochemistry, University of Queensland, St. Lucia, Queensland 4067, Australia

The micellar characteristics of chlorpromazine in 0.025 M sodium pyrophosphate-0.00125 M magnesium chloride-0.125 M sodium chloride-1.0 M sucrose, pH 6.8, 37°, have been investigated by frontal gel chromatography on Sephadex G-25. Results indicate a critical micelle concentration of 0.2 mM, a value that substantiates the necessity to consider the coexistence of monomeric and micellar forms of the drug in its interaction with tubulin under these conditions. Taken in conjunction with published results of such binding studies, this investigation provides experimental support for the concept that the micellar state of chlorpromazine interacts preferentially with one site on brain tubulin.

Submitted on April 3, 1981
Accepted on May 26, 1981







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics